These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1528937)

  • 1. Behavioural effects of anxiogenic agents in the common marmoset.
    Carey GJ; Costall B; Domeney AM; Jones DN; Naylor RJ
    Pharmacol Biochem Behav; 1992 May; 42(1):143-53. PubMed ID: 1528937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box.
    Bradley BF; Bridges NJ; Starkey NJ; Brown SL; Lea RW
    Behav Brain Res; 2011 Jan; 216(1):285-92. PubMed ID: 20723567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
    Kliethermes CL; Finn DA; Crabbe JC
    Psychopharmacology (Berl); 2003 Sep; 169(2):190-7. PubMed ID: 12783153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.
    Shimada T; Matsumoto K; Osanai M; Matsuda H; Terasawa K; Watanabe H
    Gen Pharmacol; 1995 Jan; 26(1):205-10. PubMed ID: 7713361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to the light/dark test procedure in mice.
    Hascoët M; Bourin M
    Pharmacol Biochem Behav; 1998 Jul; 60(3):645-53. PubMed ID: 9678648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
    Merlo Pich E; Samanin R
    Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine.
    Lin HQ; Burden PM; Christie MJ; Johnston GA
    Pharmacol Biochem Behav; 1999 Mar; 62(3):403-8. PubMed ID: 10080230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.
    Rodgers RJ; Cole JC; Aboualfa K; Stephenson LH
    Pharmacol Biochem Behav; 1995 Dec; 52(4):805-13. PubMed ID: 8587923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations.
    Stout JC; Weiss JM
    Pharmacol Biochem Behav; 1994 Mar; 47(3):459-65. PubMed ID: 7911574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.
    Thompson BL; Rosen JB
    Neuropharmacology; 2006 Jan; 50(1):57-68. PubMed ID: 16185722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
    Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
    Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.
    Yeung M; Lu L; Hughes AM; Treit D; Dickson CT
    Neuropharmacology; 2013 Dec; 75():47-52. PubMed ID: 23851259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of kynurenic acid to anxiogens in mice.
    Lapin IP
    Life Sci; 1998; 63(15):PL231-6. PubMed ID: 9768878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marmoset conspecific confrontation: an ethologically-based model of anxiety.
    Cilia J; Piper DC
    Pharmacol Biochem Behav; 1997 Sep; 58(1):85-91. PubMed ID: 9264075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic-like effects induced by stimulation of dopamine receptors.
    Simon P; Panissaud C; Costentin J
    Pharmacol Biochem Behav; 1993 Jul; 45(3):685-90. PubMed ID: 8101381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety.
    Baldwin HA; Johnston AL; File SE
    Eur J Pharmacol; 1989 Jan; 159(2):211-5. PubMed ID: 2707309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pharmacologically-induced experimental anxiety on nociception and antinociception in rats.
    Jiménez-Velázquez G; Fernández-Guasti A; López-Muñoz FJ
    Eur J Pharmacol; 2006 Oct; 547(1-3):83-91. PubMed ID: 16952350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rat exploratory behavior using the exploration box test.
    Otter MH; Matto V; Sõukand R; Skrebuhhova T; Allikmets L; Harro J
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):683-91. PubMed ID: 9580470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs.
    Kalueff AV; Tuohimaa P
    Eur J Pharmacol; 2005 Jan; 508(1-3):147-53. PubMed ID: 15680265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.